CD4 and acute lymphoblastic leukemia: For instance, in a study involving 46 R/R B-ALL patients, Pan et al. found that the TREG population (CD4+CD25+CD127low) in peripheral blood measured both pre- and post-CAR-T cell therapy was significantly lower in the remission group than in the non-remission group.